ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

THOR Synthorx Inc

67.99
0.00 (0.00%)
02 Aug 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Synthorx Inc NASDAQ:THOR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 67.99 67.00 67.99 0 01:00:00

Thoratec Schedules Third Quarter Conference Call, Webcast

15/10/2014 2:00pm

PR Newswire (US)


Synthorx (NASDAQ:THOR)
Historical Stock Chart


From Aug 2019 to Aug 2024

Click Here for more Synthorx Charts.

PLEASANTON, Calif., Oct. 15, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the third quarter of fiscal year 2014 on Wednesday, November 5.

The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific Standard Time (4:30 p.m., Eastern Standard Time), Wednesday, November 5, hosted by D. Keith Grossman, President and Chief Executive Officer, and Taylor C. Harris, Vice President and Chief Financial Officer.

The teleconference can be accessed by calling (719) 325-2445, passcode 6219511. Please dial in 10-15 minutes prior to the beginning of the call.  The webcast will be available on the Internet at http://edge.media-server.com/m/p/grfi2fd7/lan/en, or http://www.thoratec.com.

A replay of the conference call will be available through Wednesday, November 12, via http://www.thoratec.com, or by telephone at (719) 457-0820, passcode 6219511.

Thoratec is a world leader in therapies to address advanced-stage heart failure.  The company's products include the HeartMate II® LVAS (Left Ventricular Assist Systems) and Thoratec® VAD (Ventricular Assist Device) with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures the CentriMag® and PediMag®/PediVAS® product lines. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's website at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered trademarks of Thoratec Corporation and HeartMate III, HeartMate PHP, PVAD, IVAD and Pocket Controller are trademarks of Thoratec Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec Switzerland GmbH.

SOURCE Thoratec Corporation

Copyright 2014 PR Newswire

1 Year Synthorx Chart

1 Year Synthorx Chart

1 Month Synthorx Chart

1 Month Synthorx Chart

Your Recent History

Delayed Upgrade Clock